Patents by Inventor Philip Kropp

Philip Kropp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6500891
    Abstract: The present invention discloses a thermally conductive adhesive composition that is useful for encapsulating electronic parts. More particularly, this invention provides adhesive compositions that have 90% of the alumina particles having an average diameter sufficiently low to maintain the particles in suspension. The thermally conductive compositions of the present invention have a low viscosity and excellent thermal conductivity properties. Also contemplated is an electronic part that is encapsulated with the inventive composition, an article of manufacture having a container with the inventive composition contained therein and a method of manufacturing the inventive thermally conductive adhesive composition.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: December 31, 2002
    Assignee: Loctite Corporation
    Inventors: Philip Kropp, Robert Cross
  • Patent number: 4668678
    Abstract: New triazoloquinoxalin-1,4-diones are described as well as the use thereof as anti-allergenic agents.
    Type: Grant
    Filed: February 22, 1985
    Date of Patent: May 26, 1987
    Assignee: USV Pharmaceutical Corporation
    Inventors: Richard E. Brown, Vassil St. Georgiev, Philip Kropp, Bernard Loev
  • Patent number: 4507300
    Abstract: New triazoloquinoxalin-1,4-diones are described as well as the use thereof as anti-allergenic agents.
    Type: Grant
    Filed: June 6, 1983
    Date of Patent: March 26, 1985
    Assignee: USV Pharmaceutical Corporation
    Inventors: Richard E. Brown, Vassil St. Georgiev, Philip Kropp, Bernard Loev
  • Patent number: 4400382
    Abstract: New triazoloquinoxalin-1,4-diones are described as well as the use thereof as anti-allergenic agents.
    Type: Grant
    Filed: March 16, 1981
    Date of Patent: August 23, 1983
    Assignee: USV Pharmaceutical Corporation
    Inventors: Richard E. Brown, Vassil St. Georgiev, Philip Kropp, Bernard Loev